MANAGEMENT AND MORTALITY OF ACUTE LEUKEMIA DURING COVID-19 PANDEMIC: 8-MONTH FOLLOW-UP AT A SINGLE INSTITUTION IN PERU.

EHA Library, Jule Vasquez, 324055

OUTCOME OF TREATING PEDIATRIC LANGERHANS HISTIOCYTOSIS WITH LCH III IN TERTIARY CENTER, SAUDI ARABIA.

EHA Library, Abrar AlMohammadi, 324103

T(6;9)(P22;Q34)/DEK-NUP214-POSITIVE ACUTE MYELOID LEUKEMIA IN ADULTS IS A RARE POOR PROGNOSIS SUBTYPE AFFECTING YOUNGER PATIENTS: THE BULGARIAN EXPERIENCE

EHA Library, Gueorgui Balatzenko, 324102

CORE-BINDING FACTOR ACUTE MYELOID LEUKEMIA: RESULTS OF A TUNISIAN EXPERIENCE

EHA Library, Hend Ben Neji, 324101

REAL-LIFE EFFICACY OF FIXED-DOSE HYPOMETHYLATING AGENTS IN OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA: A SINGLE CENTER EXPERIENCE

EHA Library, Tarinee Rungjirajittranon, 324100

LIPOSOMAL ANNAMYCIN FOR R/R AML

EHA Library, Robert Shepard, 324099

A PROSPECTIVE RANDOMIZED COMPARISON OF HIGH-DOSE CYTARABINE AND HIGH-DOSE DAUNORUBICIN IN THE INDUCTION CHEMOTHERAPY FOR ACUTE MYELOID LEUKEMIA

EHA Library, Eun-Ji Choi, 324098

MUTATION SPECTRUM OF FLT3-ITD POSITIVE ACUTE MYELOID LEUKEMIA AND ITS PROGNOSTIC INDICATIONS IN A CHINESE PATIENT COHORT

EHA Library, SuJun Gao, 324097

A PHASE 1 STUDY OF NKX101, AN ALLOGENEIC CAR NATURAL KILLER (NK) CELL THERAPY, IN SUBJECTS WITH RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML) OR HIGHER RISK MYELODYSPLASTIC SYNDROME (MDS)

EHA Library, Carlos Bachier, 324096

FREQUENCY OF AN HP196–197 INSERTION (6BP) IN C/EBPΑ TAD2 REGION IN RUSSIAN POPULATION OF AML PATIENTS COMPARING TO CONTROL COHORTS.

EHA Library, Yana Kozhevnikova, 324095

REAL WORLD DATA ON THE USE OF BCL2 INHIBITION IN ACUTE MYELOID LEUKAEMIA; THE IRISH EXPERIENCE

EHA Library, Laura Mcdonald, 324094

IMPACT OF P53 AND BCL2 EXPRESSION ON PROGNOSIS IN PATIENTS WITH ACUTE MYELOID LEUKAEMIA: A TEN YEAR SINGLE CENTRE STUDY

EHA Library, Laura Mcdonald, 324093

JUVENILE MYELOMONOCYTIC LEUKEMIA IN A PATIENT WITH NOONAN SYNDROME AND FAMILIAL MEDITERRANEAN SYNDROME

EHA Library, Davit Babikyan, 324092

IDENTIFYING LEUKEMIA-ASSOCIATED IMMUNOPHENOTYPES IN ACUTE MYELOID LEUKEMIA PATIENTS USING MULTIPARAMETER FLOW CYTOMETRY

EHA Library, Hadeer Rasheed, 324091

CPX-351 IN THERAPHY RELATED ACUTE MYELOID LEUKEMIA AND ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES: A MULTICENTER REAL-LIFE EXPERIENCE IN YOUNG PATIENTS (<60 YEARS OLD)

EHA Library, Bruno Garibaldi, 324090

PHASE 1/2 FIRST IN HUMAN STUDY OF THE MENIN-KMT2A (MLL) INHIBITOR KO-539 IN PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA

EHA Library, Eunice Wang, 324089

PEVOLAM: TRIAL DESIGN FOR A RANDOMIZED PHASE 3 MULTICENTER STUDY COMPARING AZACITIDINE PLUS PEVONEDISTAT VS AZACITIDINE IN OLDER OR UNFIT PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA

EHA Library, Juan Miguel Bergua Burgues, 324088

EUROPEAN GUIDELINES AND REAL-WORLD EVIDENCE OF MAINTENANCE TREATMENTS FOR ADULTS WITH ACUTE MYELOID LEUKEMIA IN FIRST COMPLETE REMISSION

EHA Library, Moez Ahmed, 324087

FREQUENCY OF FLT3-ITD AND FLT3-TKD MUTATIONS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA: A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS

EHA Library, Juliana Lewis, 324086

REAL-WORLD TREATMENT PATTERNS AND CLINICAL OUTCOMES IN UNFIT PATIENTS WITH AML RECEIVING FIRST LINE SYSTEMIC TREATMENT OR BEST SUPPORTIVE CARE (CURRENT): A BELGIAN SUBANALYSIS

EHA Library, Leen Stas, 324085

EVALUATION OF MYELODYSPLASTIC SYNDROME AND ACUTE MYELOID LEUKEMIA PATIENTS TREATED WITH HYPOMETHYLATING AGENTS: A REAL WORLD EXPERIENCE

EHA Library, Eren Gunduz, 324084

EFFICACY AND SAFETY OF GEMTUZUMAB IN RELAPSED AND REFRACTORY AML IN REAL WORLD PRACTICE

EHA Library, Irina Budaeva, 324083

ACUTE PROMYELOCYTIC LEUKEMIA WITH PML-RARA: 10 YEARS EXPERIENCE OF A PORTUGUESE SINGLE CENTER.

EHA Library, Marco Dias, 324082

PATIENT PREFERENCES FOR MAINTENANCE THERAPY OF ACUTE MYELOID LEUKEMIA: A DISCRETE CHOICE EXPERIMENT SUBANALYSIS OF PATIENTS IN GERMANY AND ITALY

EHA Library, Katelyn Cutts, 324081

COVID-19 IN PATIENTS WITH ACUTE LEUKEMIA: THE EXPERIENCE OF A HEMATOLOGICAL CENTER

EHA Library, Alessandra Malato, 324080

KIT D816 MUTATED T(8;21)(Q22;Q22.1) ACUTE MYELOID LEUKEMIA WITH CONCURRENT SYSTEMIC MASTOCYTOSIS SHOWS POOR RESPONSE TO COMMON CHEMOTHERAPY AND TRANSPLANTATION

EHA Library, Wei Zhang, 324079

SYSTEMATIC LITERATURE REVIEW OF THE EFFICACY AND SAFETY OF MAINTENANCE THERAPIES FOR ADULTS WITH ACUTE MYELOID LEUKEMIA IN COMPLETE REMISSION WHO ARE INELIGIBLE FOR HEMATOPOIETIC STEM CELL TRANSPLANT

EHA Library, Beatrice Suero, 324078

SURVIVAL OUTCOMES AND ADVERSE EVENTS OF IDH1/2 MUTANT AML PATIENTS TREATED WITH IDH1/2 INHIBITORS: A SINGLE INSTITUTIONAL EXPERIENCE

EHA Library, Constantine Logothetis, 324077

FAVOURABLE OUTCOMES WITH ATRA AND ARSENIC VERSUS ATRA AND CHEMOTHERAPY IN NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA IN WESTERN AUSTRALIA- A POPULATION-BASED STUDY.

EHA Library, Annalise Martin, 324076

PROGNOSTIC IMPACT OF MOLECULAR MARKERS IN ELDERLY PATIENTS AFFECTED BY NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: MONOCENTRIC EXPERIENCE

EHA Library, Danilo De Novellis, 324075

A PHASE 1A/B DOSE ESCALATION STUDY OF THE MUTATION AGNOSTIC FLT3/BTK INHIBITOR LUXEPTINIB (CG-806) IN PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA

EHA Library, Rafael Bejar, 324074

RETROSPECTIVE ASSESSMENT OF TREATMENT PATTERNS AND RESOURCE UTILIZATION FOR PATIENTS NEWLY DIAGNOSED WITH ACUTE MYELOID LEUKEMIA IN CANADA, UK, FRANCE, GERMANY, ITALY, AND SPAIN

EHA Library, Manasee V. Shah, 324073

THE ROLE OF CASPASE-8 (CASP8) AND -10 (CASP10) GENE POLYMORPHISMS IN CHILDREN AND ADOLESCENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Marilena Lourou, 324037

¬HIGH FREQUENCY OF SPONTANEOUS LOSS OF HETEROZYGOSITY AND ELEVATED MICROSATELLITE ALTERATION AT SELECTED TETRANUCLEOTIDES IN LEUKEMIA CELLS STR-PROFILES: IN-VITRO TESTING OF LYMPHOBLASTOID CELL LINES

EHA Library, Natalya Risinskaya, 324038

PATHOGENETIC ROLE OF TUMOR NECROSIS FACTOR (TNF) AND TRANSFORMING GROWTH FACTOR Β1 (TGFΒ1) IN THE CHANGING OF ADHESIVE PROPERTIES OF VASCULAR ENDOTHELIUM (VE) IN ACUTE LEUKEMIA (AL)

EHA Library, Vira Barilka, 324039

EVALUATION OF BIOMATRICA’S RNASTABLE (BRS) AND NOVEL STABILIZER (CPHD1) TO PRESERVE IVT-RNA AT ROOM TEMPERATURE(RT) TO BE USED FOR CALIBRATION OF THE CEPHEID XPERT® BCR-ABL ULTRA P190 PROTOTYPE‡ ASSAY

EHA Library, Tran Tran, 324040

DEVELOPMENT OF ASSAY CALIBRATION MEHTHODOLOGY FOR CEPHEID XPERT® BCR-ABL ULTRA P190 PROTOTYPE‡ ASSAY

EHA Library, Yuanyuan LIU, 324041

BCR-ABL P190 QUANTITATION EVALUATED BY COMMERCIALLY AVAILABLE ASSAYS AND THE CEPHEID XPERT® BCR-ABL ULTRA P190 PROTOTYPE‡ASSAY

EHA Library, Adam Aslam, 324042

CGH ARRAYS REVEAL ADDITIONAL CLINICALLY RELEVANT CHROMOSOME ABNORMALITIES IN POSITIVE PHILADELPHIA ACUTE LIMPHOBLASTIC LEUKEMIA: A CASE STUDY

EHA Library, Alessandra Pansa, 324043

CHROMOSOMAL ABNORMALITIES DURING THE CLINICAL COURSE OF ADULT ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Olena Zotova, 324044

MAINTENANCE TREATMENT WITH LOW-DOSE DECITABINE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ADULT ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Rong Guo, 324045

BLINATUMOMAB FOR HLA LOSS RELAPSE AFTER HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, He Huang, 324046

INCIDENCE OF HEMATOLOGICAL MALIGNANCIES AT THE NATIONAL CANCER INSTITUTE IN PERU. A 19 YEARS’ EXPERIENCE.

EHA Library, Jule Vasquez, 324047

OUTCOME OF ADOLESCENTS AND YOUNG ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH PEDIATRIC PROTOCOL

EHA Library, Imen Ben Amor, 324048

A SINGLE-ARM, OPEN-LABEL PHASE 2 PILOT STUDY OF VYXEOS (CPX-351) IN ADULTS WITH RELAPSED OR REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA.

EHA Library, Bijal D. Shah, 324049

L-ASPARAGINASE HYPERSENSITIVITY AND SURVIVAL RELATIONSHIP IN TURKISH PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMİA PATIENTS TREATED WITH MODIFIED ST. JUDE TOTAL XV TREATMENT PROTOCOL

EHA Library, Selin Aytac, 324050

FERRITIN AS A MARKER FOR PROGNOSIS OF THYROID PATHOLOGY AND FEATURES OF THE AMINO ACIDS PROFILE IN THE LONG-TERM CARE OF CHILDREN WHO HAVE SUFFERED FOR ALL AFTER CHORNOBYL ACCIDENT

EHA Library, Katerina Bruslova, 324051

ACUTE LEUKEMIA AT ALEXANDRIA UNIVERSITY CHILDREN'S HOSPITAL: A SIX YEARS' EXPERIENCE

EHA Library, Yasmine El Chazli, 324052

CYTOGENETIC HETEROGENEITY IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA AND TRANSLOCATION T(12;21)(P13;Q22), TEL/AML1 (ETV6-RUNX1)

EHA Library, Anastasia Athanasiadou, 324053

VALIDATION OF OPTICAL GENOME MAPPING FOR DIAGNOSIS OF ACUTE LEUKAEMIA IN PEDIATRIC PATIENTS

EHA Library, Elena García Sánchez, 324054

CHILDREN ACUTE PROMYELOCYTIC LEUKEMIA: HEMATOLOGY DEPARTMENT EXPERIENCE AT AZIZA OTHMANA HOSPITAL

EHA Library, Rym Jaidi, 324104

THE IMPACT OF RISK STRATIFICATION BY EARLY BONE-MARROW RESPONSE IN CHILDHOOD T- ACUTE LYMPHOBLASTIC LEUKAEMIA (A SINGLE INSTITUTION EXPERIENCE IN AZIZA OTHMANA HOSPITAL, TUNIS, TUNISIA).

EHA Library, Ben Abdennebi Yosr, 324056

L-ASPARAGINASE ASSOCIATED ACUTE PANCREATITIS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Hale Oren, 324057

ACUTE LYMPHOBLASTIC LEUKEMIA IN ADOLESCENTS AND YOUNG ADULTS HEMATOLGY DEPARTMENT EXPERIENCE OF AZIZA OTHMANA HOSPITAL

EHA Library, Bahri Marwa, 324058

L’ASPARAGINASE ALLERGIC REACTIONS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Sabrine Mekni, 324059

ACUTE LYMPHOBLASTIC LEUKEMIA : A DECADE OF MONOCENTRIC EXPERIENCE IN MOROCCO

EHA Library, Siham Ahchouch, 324060

SEVERE HAEMOPHILIA A DIAGNOSED IN A CHILD WITH ALL: FIRST REPORT IN GREECE

EHA Library, Maria Ioannidou, 324061

B-ACUTE LYMPHOBLASTIC LEUKAEMIA/LYMPHOMA WITH ATYPICAL CLINICOPATHOLOGICAL/GENETIC FEATURES

EHA Library, Dina Sameh Soliman, 324062

PH+ ACUTE LYMPHOBLASTIC LEUKEMIA PRESENTED AS CHOLESTATIC JAUNDICE IN A 3-YEAR- OLD BOY

EHA Library, Eleni Thomaidou, 324063

BLINATUMOMAB FOR THE TREATMENT OF ADULT RELAPSED/REFRACTORY PHILADELPHIA CHROMOSOME-NEGATIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: A SINGLE-CENTER REAL-LIFE EXPERIENCE OVER TWO YEARS

EHA Library, Alexandra Elena Ghiaur, 324064

ARGENTINE REAL WORLD DATA EXPERIENCE ON GENE MUTATION PROFILING PANELS IN ACUTE MYELOID LEUKEMIA

EHA Library, Marco Lincango-Yupanki, 324065

IDENTIFICATION AND VALIDATION OF A SUBSET OF CANDIDATE FDA-APPROVED DRUGS FOR REPURPOSING IN HOXA EXPRESSING AML

EHA Library, Kate Butcher, 324066

DUAL ROLES FOR PROTEOSTATIC TARGETING IN ACUTE MYELOID LEUKAEMIA

EHA Library, William Grey, 324067

MIRNA EXPRESSION IN ADULT ACUTE MYELOID LEUKAEMIA: BIOMARKERS FOR RISK SUBGROUPS?

EHA Library, Elliott Brown, 324068

NILOTINIB INHIBITS INFLAMMATION IN ACUTE MYELOID LEUKEMIA

EHA Library, Jose Luis Marin-Rubio, 324069

SYNERGISTIC EFFECTS OF A NOVEL COMBINATION OF CLADRIBINE AND CHIDAMIDE ON CELL PROLIFERATION AND APOPTOSIS OF ACUTE MYELOID LEUKEMIA

EHA Library, Zheng Ge, 324070

A CASE OF IDH1 MUTATED AML IN AN ADULT PATIENT AFFECTED BY OLLIER DISEASE, BIOLOGICAL SPECULATIONS AND CLINICAL IMPLICATIONS

EHA Library, Giambattista Bertani, 324071

PREDICTIVE FACTORS AFFECTING THERAPY RESPONSE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Maria Kolesnikova, 324072

Patient care - part 1

EHA Library, Eoin McGrath, 313555

Abstract Book 2020

EHA Library, Faculty / Presenters, 307451

Educational Updates in Hematology 2020

EHA Library, Faculty / Presenters, 307450

Metabolomics - Can we cure cancer by metabolic conditioning?

EHA Library, Vassiliki Boussiotis, 313420

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF VENETOCLAX WITH AZACITIDINE VS AZACITIDINE IN TREATMENT-NAÏVE PATIENTS WITH ACUTE MYELOID LEUKEMIA INELIGIBLE FOR INTENSIVE THERAPY-VIALE-A

EHA Library, Courtney DiNardo, 303390

SUBCUTANEOUS DARATUMUMAB + CYCLOPHOSPHAMIDE, BORTEZOMIB, AND DEXAMETHASONE (CYBORD) IN PATIENTS WITH NEWLY DIAGNOSED LIGHT CHAIN (AL) AMYLOIDOSIS: PRIMARY RESULTS FROM THE PHASE 3 ANDROMEDA STUDY

EHA Library, Efstathios Kastritis, 303396

REAL-TIME NATIONAL SURVEY OF COVID-19 IN HEMOGLOBINOPATHY AND RARE INHERITED ANEMIA PATIENTS

EHA Library, Paul Telfer, 303394

ENDOTHELIOPATHY IS ESSENTIAL IN COVID-19 ASSOCIATED COAGULOPATHY

EHA Library, George Goshua, 303393

ISATUXIMAB PLUS CARFILZOMIB AND DEXAMETHASONE VS CARFILZOMIB AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (IKEMA): INTERIM ANALYSIS OF A PHASE 3, RANDOMIZED, OPEN-LABEL STUDY

EHA Library, Philippe Moreau, 303392

PHASE II RANDOMIZED CLINICAL TRIAL COMPARING ROPEGINTERFERON VERSUS PHLEBOTOMY IN LOW-RISK PATIENTS WITH POLYCYTHEMIA VERA. RESULTS OF THE PRE-PLANNED INTERIM ANALYSIS

EHA Library, Tiziano Barbui, 303391

Interactive session: Welcome and voting on patient cases

EHA Library, Georg Heß, 312353

Can novel approaches for early response assessment guide timely clinical decisions?

EHA Library, A Schuh, 312352

Part II: Case studies, panel discussion and Q&A - From science to practice – a step closer to personalised care in NHL? - F

EHA Library, Faculty / Presenters, 312351

Are we ready to treat high-risk patients with DLBCL differently? Personalising front-line therapy – when standard treatment

EHA Library, Ulrich Jäger, 312350

Session Opening & Current landscape in the management of multiple myeloma

EHA Library, Mohamad Mohty, 312349

Future horizons for CAR T-cells, bispecifics and other advanced therapy medicinal products in multiple myeloma

EHA Library, Hermann Einsele, 312348

Panel Discussion and Q&A

EHA Library, Faculty / Presenters, 312347

What I need to know about advanced therapy medicinal products for my clinical practice – facts or fiction: An interactive d

EHA Library, Joseph Mikhael, 312346

How molecular insights are changing the way we understand individual patients

EHA Library, Stefano Pileri, 312354

Are we ready to treat high-risk patients with DLBCL differently? Relapsed/refractory disease – a continued area of unmet me

EHA Library, H Tilly, 312355

Follicular lymphoma from genetics to the clinic

EHA Library, Gilles Salles, 313417

Impact and treatment of SCD: Hearing the patient viewpoint

EHA Library, John James, 312335

Living with SCD: Understanding the consequences

EHA Library, R Colombatti, 312334

Effective management of VOCs: Overcoming barriers and finding solutions

EHA Library, Ifeyinwa Osunkwo, 312333

COVID-19 and SCD: The experts in conversation

EHA Library, Ifeyinwa Osunkwo, 312331

Toxicities in adult versus pediatric ALL patients and consequences for management

EHA Library, K Schmiegelow, 312330

Efficacy, tolerability and management strategies in the GMALL trials

EHA Library, Nicola Gökbuget, 312329

Asparaginase pharmacokinetics and pharmacodynamics

EHA Library, M Relling, 312328

Q&A

EHA Library, Faculty / Presenters, 312327

Questions and Discussion

EHA Library, Nicola Gökbuget, 312326

Q&A

EHA Library, Faculty / Presenters, 312325

Welcome and Introduction

EHA Library, Ifeyinwa Osunkwo, 312332